Stericycle (SRCL) Price Target Raised to $75.00 at Royal Bank of Canada

Stericycle (NASDAQ:SRCL) had its target price boosted by Royal Bank of Canada to $75.00 in a research report released on Friday morning. Royal Bank of Canada currently has an underperform rating on the business services provider’s stock.

Several other research analysts have also weighed in on SRCL. BidaskClub lowered Stericycle from a hold rating to a sell rating in a research report on Thursday, January 11th. Zacks Investment Research raised Stericycle from a sell rating to a hold rating in a research report on Wednesday, January 10th. Barrington Research decreased their target price on Stericycle from $87.00 to $75.00 and set an outperform rating for the company in a research report on Friday, November 10th. Oppenheimer reaffirmed a hold rating on shares of Stericycle in a research report on Wednesday, December 13th. Finally, Jefferies Group set a $83.00 target price on Stericycle and gave the company a buy rating in a research report on Wednesday, December 13th. Three analysts have rated the stock with a sell rating, five have issued a hold rating and six have issued a buy rating to the stock. The company has a consensus rating of Hold and a consensus target price of $75.18.

Stericycle (SRCL) traded up $0.47 during mid-day trading on Friday, hitting $72.00. The stock had a trading volume of 806,360 shares, compared to its average volume of 725,795. Stericycle has a 1 year low of $61.25 and a 1 year high of $88.00. The company has a debt-to-equity ratio of 0.93, a quick ratio of 0.82 and a current ratio of 0.82. The company has a market cap of $6,190.00, a price-to-earnings ratio of -128.57, a PEG ratio of 1.74 and a beta of 0.16.

Stericycle (NASDAQ:SRCL) last posted its quarterly earnings data on Wednesday, November 8th. The business services provider reported $1.10 earnings per share for the quarter, missing the Thomson Reuters’ consensus estimate of $1.14 by ($0.04). Stericycle had a positive return on equity of 13.93% and a negative net margin of 0.79%. The business had revenue of $883.00 million during the quarter, compared to the consensus estimate of $896.81 million. During the same period last year, the business posted $1.24 earnings per share. The business’s revenue was down .8% on a year-over-year basis. equities analysts forecast that Stericycle will post 4.49 earnings per share for the current year.

In related news, Director Mark C. Miller sold 19,753 shares of the business’s stock in a transaction dated Monday, October 30th. The stock was sold at an average price of $70.52, for a total value of $1,392,981.56. Following the completion of the sale, the director now directly owns 205,576 shares of the company’s stock, valued at approximately $14,497,219.52. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Insiders sold a total of 79,012 shares of company stock valued at $5,240,668 over the last ninety days. 3.50% of the stock is currently owned by corporate insiders.

A number of hedge funds have recently added to or reduced their stakes in the business. Vanguard Group Inc. boosted its stake in Stericycle by 3.0% during the 2nd quarter. Vanguard Group Inc. now owns 8,334,537 shares of the business services provider’s stock valued at $636,092,000 after purchasing an additional 240,327 shares during the last quarter. BlackRock Inc. boosted its stake in Stericycle by 6.4% during the 2nd quarter. BlackRock Inc. now owns 5,413,244 shares of the business services provider’s stock valued at $413,139,000 after purchasing an additional 323,664 shares during the last quarter. Schroder Investment Management Group boosted its stake in Stericycle by 89.3% during the 3rd quarter. Schroder Investment Management Group now owns 1,973,743 shares of the business services provider’s stock valued at $141,556,000 after purchasing an additional 931,300 shares during the last quarter. Wells Fargo & Company MN boosted its stake in Stericycle by 7.1% during the 3rd quarter. Wells Fargo & Company MN now owns 1,898,959 shares of the business services provider’s stock valued at $136,003,000 after purchasing an additional 126,005 shares during the last quarter. Finally, Jennison Associates LLC boosted its stake in Stericycle by 0.4% during the 3rd quarter. Jennison Associates LLC now owns 1,494,643 shares of the business services provider’s stock valued at $107,046,000 after purchasing an additional 5,522 shares during the last quarter. Institutional investors and hedge funds own 94.49% of the company’s stock.

ILLEGAL ACTIVITY WARNING: “Stericycle (SRCL) Price Target Raised to $75.00 at Royal Bank of Canada” was published by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are accessing this news story on another website, it was copied illegally and republished in violation of U.S. & international copyright legislation. The original version of this news story can be accessed at https://www.dispatchtribunal.com/2018/01/20/stericycle-srcl-price-target-raised-to-75-00-at-royal-bank-of-canada.html.

Stericycle Company Profile

Stericycle, Inc is a business-to-business services provider. The Company focuses on regulated and compliance solutions for healthcare, retail, and commercial businesses. The Company’s segments include Domestic and Canada Regulated Waste and Compliance Services (RCS), Domestic Communication and Related Services (CRS), International RCS and All other.

Analyst Recommendations for Stericycle (NASDAQ:SRCL)

Receive News & Ratings for Stericycle Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stericycle and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply